Mexico:
New Platform In Connection With Pharmaceutical Patents
23 November 2020
OLIVARES
To print this article, all you need is to be registered or login on Mondaq.com.
On November 13, the Ministry of Economy and the Ministry of
Health in conjunction with the Mexican Patent and Trademark Office
(IMPI) and the regulatory authority (COFEPRIS), announced a new
platform for the generation of a greater number of generics in the
country.
The platform mainly consists of the following databases for drug
patents:
- Patents of drugs according to the
generic name, non-proprietary name.
- Drug patents whose validity is soon
to expire,
- Responses to intergovernmental
consultations between IMPI and COFEPRIS in accordance with the
patent linkage system (see newsletter https://bit.ly/32SMhlL).
The transparency, access and ease of information is positive. We
will shortly be giving more details on the general operation of
this new platform and its implications on the linking system.
The content of this article is intended to provide a general
guide to the subject matter. Specialist advice should be sought
about your specific circumstances.
POPULAR ARTICLES ON: Intellectual Property from Mexico
Update On Divisional Applications In Mexico
OLIVARES
Divisional practice is important for almost any company interested in obtaining patent protection in certain regions. In Mexico, divisional applications have been filed throughout the years...
Requirements For Obtaining A Patent
Leão Advogados Associados
A patent is a technical document with legal purposes. Technical because it must describe an industrial creation and legal because it defines...
Patents Comparative Guide
Basham, Ringe y Correa, S.C.
Patents Comparative Guide for the jurisdiction of Mexico, check out our comparative guides section to compare across multiple countries
Mexico Patent Litigation 2024
OLIVARES
Patent litigation in Mexico is taken before the Mexican Institute of Industrial Property (in the foregoing IMPI). IMPI has enough authority for ruling on infringement...